Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease.

@article{Kanbay2011UricAA,
  title={Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease.},
  author={Mehmet Kanbay and Mustafa Ikizek and Yalçin Solak and Yusuf Selcoki and Sema Uysal and Ferah Armutcu and Beyhan Eryonucu and Adrian A. Covic and Richard J Johnson},
  journal={American journal of nephrology},
  year={2011},
  volume={33 4},
  pages={
          325-31
        }
}
BACKGROUND AND OBJECTIVES Cardiovascular disease is prevalent in chronic kidney disease (CKD). Uric acid is increased in subjects with CKD and has been linked with cardiovascular mortality in this population. However, no study has evaluated the relationship of uric acid with angiographically proven coronary artery disease (CAD) in this population. We therefore investigated the link between serum uric acid (SUA) levels and (i) extent of CAD assessed by the Gensini score and (ii) inflammatory… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 24 CITATIONS

Associations between pentraxin 3 and severity of coronary artery disease

  • BMJ open
  • 2015
VIEW 4 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED

Dietary and commercialized fructose: Sweet or sour?

  • International Urology and Nephrology
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 52 REFERENCES

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk

M Goicoechea, SG de Vinuesa, U Verdalles
  • Clin J Am Soc Nephrol 2010;
  • 2010